Cervical spondylotic radiculopathy (CSR) is one of the most common and dominant orthopedic diseases. However, none of the existing CSR guidelines/consensus provide recommendations related to the diagnosis and treatment of CSR with integrated Chinese and Western medicine. To help practitioners in different medical systems to make better CSR diagnosis and treatment decisions, it is urgent to formulate clinical practice guidelines based on evidence-based medicine. This protocol describes the crucial links in formulating the Guideline for the diagnosis and non-surgical treatment of cervical spondylotic radiculopathy by integrated traditional Chinese and Western medicine (2023), aiming to provide guidance and outline implementation plan for the scientific formulation of this guideline and promote its standardized, efficient and transparent development.

1.神经根型颈椎病诊疗规范化研究专家组. 神经根型颈椎病诊疗规范化的专家共识[J]. 中华外科杂志, 2015, 53: 812-814. [Standardized Research Expert Group on the Diagnosis and Treatment of Cervical Radiculopathy. Expert consensus on the standardization of diagnosis and treatment of cervical radiculopathy[J]. Chinese Journal of Surgery, 2015, 53: 812-814.] DOI: 10.3760/cma.j.issn.0529-5815.2015.11.004.

2.中华中医药学会. 中华中医药学会（ZYYXH/T372-415-2012）：中医骨伤科常见病诊疗指南[S]. 北京：中国中医药出版社, 2012: 134-138.

3.Radhakrishnan K, Litchy WJ, O'Fallon WM, et al. Epidemiology of cervical radiculopathy. A population-based study from Rochester,  Minnesota, 1976 through 1990[J]. Brain, 1994, 117 (Pt 2): 325-335. DOI: 10.1093/brain/117.2.325.

4.Carette S, Fehlings MG. Clinical practice. Cervical radiculopathy[J]. N Engl J Med, 2005, 353: 392-399. DOI: 10.1056/NEJMcp043887.

5.Wei X, Wang S, Li J, et al. Complementary and alternative medicine for the management of cervical radiculopathy: an overview of systematic reviews[J]. Evid Based Complement Alternat Med, 2015, 2015: 793649. DOI: 10.1155/2015/793649.

6.彭志军, 曹立幸, 陈志强, 等. “症病学说”——中西医结合临床决策思考[J]. 时珍国医国药, 2023, 34: 151-152. [Peng ZJ, Cao LX, Chen ZQ, et al. "The theory of symptomatic disease": thinking on clinical decision-making of integrated traditional Chinese and western medicine[J]. Lishizhen Medicine and Materia Medica Research, 2023, 34: 151-152.] DOI: 10.3969/j.issn.1008-0805.2023.01.40.

7.吕文良, 王丽, 汪青楠. 新时代下对促进中西医结合发展的思考[J]. 中国科学基金, 2023, 37(1): 67-71. [Lyu WL, Wang L, Wang QN. Reflections on promoting the development of integrated traditional Chinese and western medicine in the new era[J]. Bulletin of National Natural Science Foundation of China, 2023, 37(1): 67-71.] DOI: 10.16262/j.cnki.1000-8217.20230215.002.

8.陈薇, 刘建平. 中西医结合临床实践指南制定原则和流程[J]. 中国中西医结合杂志, 2022, 42(12): 1413-1417. [Chen W, Liu JP. Principles and procedures for the formulation of clinical practice guidelines for integrated traditional Chinese and Western medicine[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2022, 42(12): 1413-1417.]DOI: 10.7661/j.cjim.20221010.030.

9.姚沙, 卢传坚, 陈耀龙, 等. 中医(中西医结合)临床实践指南制修订方法——指南的定义与分类[J]. 中华中医药杂志, 2016, 31(1): 165-168. [Yao S, Lu CJ, Chen YL, et al. Methodology on development and revision for Chinese medicine (integrative medicine) clinical practice guidelines: the definition and classification of clinical practice guidelines[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2016, 31(1): 165-168.]

10.Bono CM, Ghiselli G, Gilbert TJ, et al. An evidence-based clinical guideline for the diagnosis and treatment of cervical  radiculopathy from degenerative disorders[J]. Spine J, 2011, 11(1): 64-72. DOI: 10.1016/j.spinee.2010.10.023.

11.中国针灸学会. ZJ/T E006-2015循证针灸临床实践指南神经根型颈椎病[S]. 北京：中国中医药出版社, 2015: 1-77.

12.Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice Guidelines, Field MJ, Lohr KN, et al. Clinical practice guidelines: directions for a new program. Washington (DC): National Academies Press (US), 1990. DOI: 10.17226/1626.

13.World Health Organization. WHO handbook for guideline development, 2nd Edition[EB/OL].(2014-12-18)[2023-4-14]. https://www.who.int/publications/i/item/9789241548960.

14.Brouwers MC, Kerkvliet K, Spithoff K. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines[J]. BMJ, 2016,352:i1152. DOI: 10.1136/bmj.i1152.

15.Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health  care[J]. J Clin Epidemiol, 2010, 182(18): 839-842. DOI: 10.1503/cmaj.090449.

16.Chen Y, Yang K, Marusic A, et al. A Reporting tool for practice guidelines in health care: The RIGHT statement[J]. Ann Intern Med, 2017, 166(2): 128-132. DOI: 10.7326/M16-1565.

17.陈耀龙, 马艳芳, 周奇, 等. 谁应该参与临床实践指南的制订?[J]. 协和医学杂志, 2019, 10(5): 524-530. [Chen YL, Ma YF, Zhou Q, et al. Who should participate in the development of clinical practice guidelines?[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(5): 524-530.] DOI: 10.3969/j.issn.1674-9081.2019.05.017.

18.国家市场监督管理总局, 国家标准化管理委员会. GB/T 15657—2021 中医病证分类与代码[S]. 北京：中国标准出版社, 2021: 15.

19.Harada T, Abe T, Kato F, et al. Five-point Likert scaling on MRI predicts clinically significant prostate  carcinoma[J]. BMC Urol, 2015, 15: 91. DOI: 10.1186/s12894-015-0087-5.

20.Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of  recommendations[J]. BMJ, 2008, 336(7650): 924-926. DOI: 10.1136/bmj.39489.470347.AD.

21.Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of  systematic reviews[J]. BMC Med Res Methodol, 2007,7:10. DOI: 10.1186/1471-2288-7-10.

22.Whiting P, Savovic J, Higgins JP, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed[J]. J Clin Epidemiol, 2016,69:225-234. DOI: 10.1016/j.jclinepi.2015.06.005.

23.Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022. [M/OL](2022-5-14)[2023-4-14]. www.training.cochrane.org/handbook.

24.Deeks JJ, Bossuyt PM, Leeflang MM, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy. 1st edition[M]. Chichester (UK): John Wiley & Sons, 2023. https://methods.cochrane.org/sdt/handbook-dta-reviews.

25.Ma LL, Wang YY, Yang ZH, et al. Methodological quality (risk of bias) assessment tools for primary and secondary  medical studies: what are they and which is better?[J]. Mil Med Res, 2020, 7(1): 7. DOI: 10.1186/s40779-020-00238-8.

26.Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised  trials[J]. BMJ, 2011, 343: d5928. DOI: 10.1136/bmj.d5928.

27.Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of  interventions[J]. BMJ, 2016, 355: i4919. DOI: 10.1136/bmj.i4919.

28.Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the  quality of nonrandomized studies in Meta-analyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605. DOI: 10.1007/s10654-010-9491-z.

29.Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J]. Ann Intern Med, 2011, 155(8): 529-536. DOI: 10.7326/0003-4819-155-8-201110180-00009.

30.王云云, 邓通, 黄桥, 等. 临床实践指南制订方法——GRADE在诊断试验系统评价中的应用[J]. 中国循证心血管医学杂志, 2019, 11(3): 275-279. [Wang YY, Deng T, Huang Q, et al. Methodology for clinical practice guidelines: application of GRADE in systematic review of diagnostic tests[J]. Chinese Journal of Evidence-Bases Cardiovascular Medicine, 2019, 11(3): 275-279. DOI: 10.3969/j.issn.1674-4055.2019.03.03.

31.王小钦, 王吉耀. 循证临床实践指南制定与实施[M]. 北京: 人民卫生出版社, 2015: 13-14. [Wang XQ, Wang JY. Development and implementation of evidence-based clinical practice guidelines[M]. Beijing: People's Medicine Publishing House,  2015: 13-14.

32.邓通, 汪洋, 王云云, 等. 临床实践指南制订方法——GRADE在观察性系统评价中的应用[J]. 中国循证心血管医学杂志, 2019, 11(2): 129-133. [Deng T, Wang Y, Wang YY, et al. Methodology for clinical practice guideline: application of GRADE in observational system evaluation[J]. Chinese Journal of Evidence-based Cardiovascular Medicine, 2019, 11(2): 129-133.] DOI: 10.3969/j.issn.1674-4055.2019.02.01.

33.Guyatt GH, Oxman AD, Kunz R, 等. GRADE:从证据到推荐[J]. 中国循证医学杂志, 2009, 9(3): 257-259. [Guyatt GH, Oxman AD, Kunz R, et al. GRADE: going from evidence to recommendations[J]. Chinese Journal of Evidence-Based Medicine, 2009, 9(3): 257-259.] DOI: 10.3969/j.issn.1672-2531.2009.03.002.

34.Schünemann HJ, Oxman AD, Brozek J, 等. 诊断性试验和策略的证据质量和推荐强度的分级[J]. 中国循证医学杂志, 2009, 9(5): 503-508. [Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies[J]. Chinese Journal of Evidence-Based Medicine, 2009, 9(5): 503-508.] DOI: 10.3969/j.issn.1672-2531.2009.05.003.

35.Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when  consensus is elusive[J]. BMJ, 2008, 337: a744. DOI: 10.1136/bmj.a744.

36.Xie YL, Han F, Jin YH, et al. Organic integration of traditional Chinese and western medicines-future of clinical practice guidelines of integrated traditional Chinese and western  medicines[J]. Chin J Integr Med, 2023. DOI: 10.1007/s11655-023-3739-9.